Saiprasad Patil

Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial

Zarir Udwadia, Pawan Singh, Hanmant Barkate et al. · International Journal of Infectious Diseases · 2020 · 291 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Expert Consensus on Effective Management of Chemotherapy-Induced Nausea and Vomiting: An Indian Perspective

Ashok K. Vaid, Sudeep Gupta, Dinesh Doval et al. · Frontiers in Oncology · 2020 · 26 citations · Full text

Medicine, Oncology, Pharmacology +17

In Vitro Fractional Inhibitory Concentration (FIC) Study of Cefixime and Azithromycin Fixed Dose Combination (FDC) Against Respiratory Clinical Isolates

Saiprasad Patil · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · 2015 · 16 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Indian consensus on the management of CRE infection in critically ill patients (ICONIC) — India

Rajeev Soman, Balaji Veeraraghavan, Ashit Hegde et al. · Expert Review of Anti-infective Therapy · 2019 · 13 citations

Pharmacy, Infectious Diseases, Microbiology +17

Efficacy and safety of single-inhaler triple therapy of glycopyrronium, formoterol and fluticasone in patients with COPD: a double-blind, randomised controlled trial

Sundeep Salvi, Akash Balki, Srikanth V. Krishnamurthy et al. · ERJ Open Research · 2021 · 13 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17